The Spike Protein
Contrary to early claims that the spike protein produced by vaccination was harmless, substantial evidence now indicates it is biologically active and potentially toxic to human cells. Oldfield et al. (2023) concluded that "the spike protein is toxic and can have serious immune consequences."
The biological activity of the spike protein raises serious questions about the wisdom of instructing human cells to produce this protein in unpredictable quantities for undefined periods, especially when repeated booster doses are administered.
The spike protein can directly damage vascular endothelial cells, potentially leading to blood clotting, inflammation, and microvascular injury.
Evidence suggests spike protein can disrupt normal immune function, potentially triggering autoimmune responses and prolonged inflammation.
Studies have demonstrated the spike protein's ability to cause damage to various organs, including the heart, brain, and reproductive tissues.
A fundamental yet underexplored issue with mRNA vaccines involves the synthetic modifications made to the mRNA itself. The vaccines use N1-methyl-pseudouridine instead of natural uridine to evade immune detection, but this modification appears to introduce significant translation errors.
According to research cited by Oldfield et al. (2023), "Slippery sequences... caused the ribosomes to skip or misread codons... producing aberrant spike protein products." This finding is critically important because it means the body may be producing proteins that differ from those intended and tested, with unknown health consequences.
These translation errors raise serious concerns about the true nature of the proteins being produced following vaccination. If human cells are manufacturing aberrant proteins not accounted for in safety testing, this could help explain the wide range of adverse events observed in post-vaccination surveillance that seem unrelated to expected spike protein effects.
"The modified mRNA not only produces the intended spike protein but may also generate frame-shifted proteins with completely different amino acid sequences. These novel proteins have unknown biological activities and immunogenicity." — Molecular biologist cited in recent literature
Contrary to early claims that the spike protein produced by vaccination would be quickly eliminated from the body, research by Patterson et al. published in Frontiers in Immunology (2022) found that "S1 protein [was] found in CD16+ monocytes in both severe COVID and long COVID patients" up to 15 months after infection or vaccination.
This alarming finding suggests that spike protein can persist in the body for extended periods, potentially causing ongoing inflammation and immune dysregulation. The study found spike protein fragments in monocytes, a type of immune cell that circulates throughout the body, which could explain the wide range of symptoms reported after vaccination.
"The persistence of spike protein in circulating immune cells may provide a mechanism for the development of post-vaccine syndromes that mirror long COVID symptoms." — Patterson et al., 2022
This research directly challenges the regulatory assumption that the mRNA and resulting spike protein would be rapidly degraded and eliminated from the body. Instead, it appears that spike protein production may continue for months or even years in some individuals, raising serious questions about long-term health impacts that were never evaluated in clinical trials.
© 2025 — All Rights Reserved.